Brief: Akoustis Technologies Appeals Qorvo Litigation
02/12/2024 11:23
Dec 2 (Reuters) - Akoustis Technologies AKTS.O :
* AKOUSTIS TECHNOLOGIES INC - APPEALS QORVO LITIGATION
* AKOUSTIS TECHNOLOGIES INC SAYS EVALUATING IMPACT OF
JUDGMENT ON
BUSINESS, RESULTS OF OPERATIONS, AND FINANCIAL CONDITION
Source text: ID:n0001213900-24-104185
Further company coverage: AKTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut